No info available.

• Nanoscale 2023 Emerging Investigators - Royal Society of Chemistry (01/01/2023-12/31/2023)
• Biomaterials Science Emerging Investigator Series 2022 - Royal Society of Chemistry (01/01/2022-12/31/2022)
• Emerging Leaders in Pharmaceutical and Biomedical Sciences 2022 - Pharmaceutical Research (01/01/2022-12/31/2022)
• Teacher of the Year (P1) Award 2021 - School of Pharmacy (08/23/2021)
• Controlled Release Society Young Investigator Award (Oral Delivery) - Controlled Release Society (07/22/2021)
• School of Pharmacy Scholar Award - School of Phaemacy (01/29/2021)

• Ph D in Bioengineering, Korea National University of Transportation (2014)
• MS in Bioengineering, Korea National University of Transportation (2010)
• B.Pharm. in Pharmaceutics, University of Development Alternative (2007)

• Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism Clinical and Translational Medicine 12 12 (2022), Mayra A. Gonzalez, Idaly M. Olivas, Alfonso E. Bencomo‐Alvarez, Andres J. Rubio, Christian Barreto‐Vargas, Jose L. Lopez, Sara K. Dang, Jonathan P. Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V. Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N. Apaflo, Efren Alvidrez, James E. Young, Joshua J. Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E. Varley, Clinton C. Mason, Christopher A. Eide, Brian J. Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M. Eiring.
• Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 12 (2022), M A. Gonzalez, I M. Olivas, A E. Bencomo-Alvarez, A J. Rubio, C Barreto-Vargas, J L. Lopez, S K. Dang, J P. Solecki, E McCall, G Astudillo, V V. Velazquez, K Schenkel, K Reffell, M Perkins, N Nguyen, J N. Apaflo, E Alvidrez, J E. Young, J J. Lara, D Yan, A Senina, J Ahmann, K E. Varley, C C. Mason, C A. Eide, B J. Druker, Md Nurunnabi, O Padilla, Sudip Bajpeyi, A M. Eiring.
• Mucoadhesive carriers for oral drug delivery Journal of Controlled Release 351 (2022), Raj Kumar, Tamanna Islam, Md Nurunnabi.
• Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma Journal of Controlled Release 349 (2022), Md N. Huda, Isaac G. Deaguero, Edgar A. Borrego, Raj Kumar, Tamanna Islam, Humayra Afrin, Armando Varela-Ramirez, Renato Aguilera, Eden E. Tanner, Md Nurunnabi.
• Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. Journal of controlled release : official journal of the Controlled Release Society 349 (2022), M N. Huda, I G. Deaguero, E A. Borrego, R Kumar, T Islam, H Afrin, A Varela-Ramirez, Renato Aguilera, Tanner EEL, Md Nurunnabi.
• Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes ACS Applied Materials & Interfaces 14 33 (2022), Humayra Afrin, Md N. Huda, Tamanna Islam, Beu P. Oropeza, Efren Alvidrez, Muhammad I. Abir, Thomas Boland, David Turbay, Md Nurunnabi.
• Bioinspired and Biomimetic Materials for Drug Delivery Woodhead Publishing (Elsevier) (2022), Md Nurunnabi.
• Bile acid linked β-glucan nanoparticles for liver specific oral delivery of biologics. Biomaterials science 10 11 (2022), A S. Chowdhury, R Geetha Bai, T Islam, Muhammad I. Abir, Mahesh Narayan, Zehedina Khatun, Md Nurunnabi.
• Potential Application of Exosomes in Vaccine Development and Delivery Pharmaceutical Research (2022), Md Nurunnabi, Md Nurul Huda.
• Detection of Leptin Using Electrocatalyst Mediated Impedimetric Sensing ACS BIOMATERIALS SCIENCE \& ENGINEERING (2022), Tamanna Islam, Md A. Ahsan, Masud Hassan, Humayra Afrin, Jaqueline Pena-Zacarias, Ali Aldalbahi, Bonifacio Alvarado-Tenorio, Juan C. Noveron, Md Nurunnabi.
• Graphene: A Promising Theranostic Agent Springer Singapore (2022), Shaimum Shahriar, Md Nafiujjaman, Jeong M. An, Vishnu Revuri, Md. Nurunnabi, Dong-Wook Han, Yong-kyu Lee.
• Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics Chinese Chemical Letters (2022), Humayra Afrin, Christiancel J. Salazar, Mohsin Kazi, Syed R. Ahamad, Majed Alharbi, Md Nurunnabi.
• Investigation of coagulation process of wet-spun sodium alginate polymannuronate fibers with varied functionality using organic coagulants and cross-linkers Materials Today Chemistry 22 (2021), T.H. Aneem, S.Y. Wong, H. Afrin, Md Nurunnabi, XiuJun (James) Li, M.T. Arafat.
• Delivery strategies of amphotericin B for invasive fungal infections. Acta pharmaceutica Sinica. B 11 8 (2021), X Wang, I S. Mohammad, L Fan, Z Zhao, M Nurunnabi, M A. Sallam, J Wu, Z Chen, L Yin, W He.
• Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials science 9 14 (2021), MMH Chowdhury , CJJ Salazar , M Nurunnabi.
• Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications ACS Biomaterials Science & Engineering 7 6 (2021), Md N. Huda, Md Nafiujjaman, Isaac G. Deaguero, Jude Okonkwo, Meghan L. Hill, Taeho Kim, Md Nurunnabi.
• Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis. BMC pregnancy and childbirth 21 1 (2021), P Dubey, B Thakur, S Reddy, C A. Martinez, M Nurunnabi, S L. Manuel, S Chheda, C Bracamontes, A K. Dwivedi.
• Application of carbon nano onions in the biomedical field: recent advances and challenges Biomater. Sci. (2021), Jyoti Ahlawat, Shima Masoudi Asil, Gileydis Guillama Barroso, Md Nurunnabi, Mahesh Narayan.
• Application of carbon nano onions in the biomedical field: recent advances and challenges RSC Biomaterials Science 9 (2021), Jyoti Ahlawat, Shima Masoudi Asil, Gileydis Guillama Barroso, Md Nurunnabi, Mahesh Narayan.
• Chapter seven - Bile acid transporter as a bioinspired method for oral therapeutics delivery system Woodhead Publishing (2021), Shaimum Shahriar, Mohammad N. Hasan, Md Nurunnabi, Yong-kyu Lee.
• Chapter SIX - Bioinspired and biomimetic materials for oral drug delivery Woodhead Publishing (2021), Mohammad N. Hasan, S.M. S. Shahriar, Jagannath Mondal, Md Nurunnabi, Yong-kyu Lee.
• Chapter thirTEEN - Bioengineering approach for pulmonary drug delivery Woodhead Publishing (2021), Ali Keshavarz, Hossam Kadry, Ahmed Alobaida, Md Nurunnabi, Taslim A. Al-Hilal.
• Design Principles for Ionic Liquids in Drug Delivery Systems Springer Singapore (2021), Md. R. Chowdhury, Md. Nurunnabi, Masahiro Goto.
• Exosome-mediated bioinspired drug delivery Elsevier (2021), Md N. Huda, Jade E. Zicari, Md Nurunnabi.
• Microorganism-mediated drug delivery Elsevier (2021), Tamanna Islam, Md M. Hasan, A. J. Ahammad, Md Nurunnabi.
• Theoretical and Experimental Insights into the Possible Interfacial Interactions between β-Glucan and Fat Molecules in Aqueous Media The Journal of Physical Chemistry B 125 50 (2021), Tamanna Islam, Md. N. Huda, Md A. Ahsan, Humayra Afrin, Joseph J Salazar, Christiancel, Md Nurunnabi.
• Physical triggering strategies for drug delivery Advanced Drug Delivery Review 158 (2020), Md Nurunnabi, Tao Sun, Anshuman Dasgupta , Zongmin Zhao , Samir Mitragotri.
• Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro. Pharmaceutics 12 6 (2020), I G. Deaguero, M N. Huda, V Rodriguez, J Zicari, Taslim A. Al-Hilal, Badruddoza AZM, Md Nurunnabi.
• Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro. Pharmaceutics 12 6 (2020), I G. Deaguero, M N. Huda, V Rodriguez, J Zicari, Taslim A. Al-Hilal, Badruddoza AZM, Md Nurunnabi.
• Nano-vesicle based Miconazole formulation has higher anti-fungal efficacy Pharmaceutics (2020), Isaac Deaguero, Md Nurul Huda, Victor Rodriguez, Jade Zicari, Taslim A. Al-Hilal, Md Nurunnabi.
• Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer. Bioengineering & translational medicine 6 1 (2020), D C. Pan, V Krishnan, A K. Salinas, J Kim, T Sun, S Ravid, K Peng, D Wu, M Nurunnabi, J A. Nelson, Z Niziolek, J Guo, S Mitragotri.
• Hyaluronic Acid‐Doxorubicin Nanoparticles for Targeted Treatment of Colorectal Cancer Bioengineering & Translational Medicine (2020), Daniel C. Pan, Vinu Krishnan, Alyssa K. Salinas, Jayoung Kim, Tao Sun, Sagi Ravid, Kevin Peng, Debra Wu, Md Nurunnabi, Jeffery A. Nelson , Zachary Niziolek , Junling Guo , Samir Mitragotri.
• Reply to Peiretti et al.: Effect of CAGE on fat uptake and food intake Proceedings of the National Academy of Sciences (2020), Md Nurunnabi, Kelly N. Ibsen, Eden E. Tanner, Samir Mitragotri.
• Green Chemistry Synthesis of Silver Nanoparticles and Their Potential Anticancer Effects Cancers (2020), ZA Ratan , MF Haidere, Md Nurunnabi, SM Shahriar, AJS Ahammad, YY Shim , MJT Reaney, JY Cho.
• Deciphering the Role of Quaternary N in O2 Reduction over Controlled N-Doped Carbon Catalysts Chemistry of Materials 32 4 (2020), Enamul Haque, Ali Zavabeti, Nizam Uddin, Yichao Wang, Md Arifur Rahim, Nitu Syed, Kai Xu, Azmira Jannat, Farjana Haque, Bao Yue Zhang, Mahbubul Alam Shoaib, Sayed Shamsuddin, Md Nurunnabi, Andrew I Minett, Jian Zhen Ou, Andrew T Harris.
• Aqueous Dispersion of One-Dimensional van der Waals Material Mo6S3I6 with the Charge Type of the Hydrophobic Dispersant Tail ACS Applied Bio Materials 3 7 (2020), Sudong Chae, Seungbae Oh, Kyung H. Choi, Jiho Jeon, Zhixiang Liu, Cong Wang, Changmo Lim, Xue Dong, Chaeheon Woo, Ghulam Asghar, Jongwha Chang, Md Nurunnabi, Joohoon Kang, Si Y. Song, Hak K. Yu, Jae-Young Choi.
• Metal Nanoparticles for Electrochemical Sensing: Progress and Challenges in the Clinical Transition of Point-of-Care Testing Molecules 25 24 (2020), Tamanna Islam, Md. M. Hasan, Abdul Awal, Md Nurunnabi, A. J. Ahammad.
• Oral ionic liquid for the treatment of diet-induced obesity Proceedings of the National Academy of Sciences (2019), Md Nurunnabi, Kelly N. Ibsen, Eden E. Tanner, Samir Mitragotri.
• Biomedical Applications of Graphene and 2D Nanomaterials Elsevier 1 (2019), Md Nurunnabi.
• Biomaterials and Bioengineering Approaches for Mitochondria and Nuclear Targeting Drug Delivery ACS BIOMATERIALS SCIENCE & ENGINEERING 5 4 (2019), Md Nurunnabi, Zehedina Khatun, Badruddoza, Abu Zayed Md, Jason R. McCarthy, Yong-kyu Lee, Kang M. Huh.
• Biocompatibility Assessment of Nanomaterials Using Zebra Fish as a Model (2019), Md Nurunnabi.
• Synthesis and characterization of bioreducible cationic biarm polymer for efficient gene delivery. International journal of biological macromolecules 110 (2018), , S Uthaman, Md Nurunnabi, S Mallick, K S. Oh, S W. Kang, S Cho, , Y K. Lee, K M. Huh.
• Effects of polymer-coated boron nitrides with increased hemorheological compatibility on human erythrocytes and blood coagulation CLINICAL HEMORHEOLOGY AND MICROCIRCULATION 70 3 (2018), Jeongho Kim, Md Nafiujjaman, Md Nurunnabi, Sinye Lim, Yong-Kyu Lee, Hun-Kuk Park.
• A targeted graphene nanoplatform carrying histamine dihydrochloride for effective inhibition of leukemia-induced immunosuppression. Journal of biomaterials science. Polymer edition 29 7-9 (2018), K Cherukula, Md Nurunnabi, Y Y. Jeong, Y K. Lee, I K. Park.
• Effects of polymer-coated boron nitrides with increased hemorheological compatibility on human erythrocytes and blood coagulation. Clinical hemorheology and microcirculation 70 3 (2018), J Kim, M Nafiujjaman, Md Nurunnabi, Siang C. Lim, Y K. Lee, H K. Park.

• Bioengineering approach for obesity diagnosis and treatment (2022), Volume Dhaka, Bangladesh, Md Nurunnabi.
• Biomedical tools for hispanic health diagnosis and therapy (2022), Volume Juarez Mexico, Md Nurunnabi.
• Ionic liquid mediated topical drug delivery (2022), Volume San Juan, Puerto Rico, Md Nurunnabi.
• Nanoparticle mediated cardiotoxicity detection (2022), Volume San Juan, Puerto Rico, Md Nurunnabi.
• Point-of-care tools for non0invasive detection of gastric cancer precursor (2022), Volume San Antonio, Texas, Md Nurunnabi.
• Topical BCL-2/BCL-xL inhibitor reverses bleomycin-induced skin fibrosis (2022), Volume New Orleans, LA, Md Nurunnabi.
• Topical delivery of BCL-2 inhibitors can treat scleroderma and early-stage melanoma (2022), Volume Montreal Canada, Md Nurunnabi.
• Potential of BCL-2 inhibitors to treat cancer and fibrosis (2022), Volume Florida, Md Nurunnabi.
• HEALTHY SAFETY IN SPACE: WHERE DO STAND, BUT WHERE SHOULD WE FORWARD (2022), Volume El Paso, Texas, Md Nurunnabi.
• DEVELOPMENT OF ORAL MEDICINE PLATFORM TO OVERCOME EXISTING BARRIERS IN SPACE PAYLOAD AND DEBRIS (2022), Volume El Paso, TX, Md Nurunnabi, Stephanie Varagas.
• Impact of radiation in cardiac tissue and real time monitoring (2022), Volume El Paso, TX, Md Nurunnabi, Humayra Afrin.
• Potential application of Biosensor in Space Health (2022), Volume El Paso, TX, Md Nurunnabi, Tamanna Islam.
• Space Medicine- a space health program of Aerospace Center (2022), Volume El Paso, Md Nurunnabi.
• Oral Medicine to Treat Obesity (2022), Volume Salt Lake City, Md Nurunnabi.
• Oral Nanoparticles to Treat Obesity (2022), Volume Virtual, Md Nurunnabi.
• Targeting delivery of BCL-2 family protein inhibitors has potential to treat cancer and fibrosis (2021), Volume Montreal, Canada, Md Nurunnabi.
• Noninvasive detection of cardiotoxicity induced by chemotherapeutic (2021), Volume Boston, MA, Md Nurunnabi, Humayra Afrin.
• Noninvasive detection of cardiotoxicity induced by chemotherapeutic (2021), Volume El Paso, Texas, Md Nurunnabi, Humayra Afrin.
• Chemical and physical interactions between β-glucan and fat molecule in aqueous media (2021), Volume Austin, Texas, Md Nurunnabi, Tamanna Islam.
• Ionic Liquid Mediated Topical Delivery of Navitoclax for Accelerate Skin Melanoma Treatment (2021), Volume Virtual, Md Nurunnabi, Md Nurul Huda.
• Oral delivery of leptin in association of fat trapping materials to treat diet induced obesity (2021), Volume Virtual, Md Nurunnabi.
• Rational Design of Biomolecules to Overcome Biological Barriers  (2021), Md Nurunnabi.
• Bioengineered formulation for cellular/subcellular specific delivery of diagnostic and therapeutic  (2021), Md Nurunnabi.
• Bioengineered formulation for cellular/subcellular specific delivery of diagnostic and therapeutic  (2021), Md Nurunnabi.
• Oral Medicine to Treat Obesity and Diabetes (2021), Md Nurunnabi.
• Bioengineered Oral Medicine to Treat Diabetes and Obesity (2020), Volume Virtual, Md Nurunnabi.
• Potential of Ionic Liquid for treating obesity (2020), Volume Madison, (Virtual), Md Nurunnabi.
• Materials in Medicine: Targeting Therapy and Imaging (2020), Volume New Mexico, Md Nurunnabi.
• Bioengineering of materials for advancement in diagnosis and therapy (2020), Volume UTEP, El Paso, Md Nurunnabi.
• Bioengineered approached to control diabetes and obesity (2019), Volume Guyana, Md Nurunnabi.
• Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes (2019), Volume El Paso, Md Nurunnabi.
• From Materials to Medicine (2019), Volume El Paso, Md Nurunnabi.

No info available.